[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370401-105":59,"doc-detail-370401-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","identifying-chemotherapy-beneficiaries-in-nasal-and-paranasal-sinus-cancers-epidemiological-trends-and-machine-learning-insights","Identifying chemotherapy beneficiaries in nasal and paranasal sinus cancers - epidemiological trends and machine learning insights","","Epidemiological characteristics, treatment strategies, and prognosis for nasal and paranasal sinus cancer remain insufficiently studied. The study evaluates age-adjusted incidence from 1975 to 2020 using SEER data and examines patients diagnosed between 2004 and 2015 with SEER*Stat, validating retrospectively with an external Fujian Provincial Cancer Hospital cohort (2013–2020). Missing data are handled via multiple imputation in R. Survival is assessed by Kaplan–Meier and Cox models, and ten machine-learning models in Python predict survival outcomes.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identifying-chemotherapy-beneficiaries-in-nasal-and-paranasal-sinus-cancers-epidemiological-trends-and-machine-learning-insights/370401/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identifying-chemotherapy-beneficiaries-in-nasal-and-paranasal-sinus-cancers-epidemiological-trends-and-machine-learning-insights/370401.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What data sources and time ranges are used in the study?","Question",{"text":112,"@type":113},"Age-adjusted incidence rates are analyzed from 1975 to 2020 using SEER data. Patients diagnosed between 2004 and 2015 are examined with SEER*Stat, and an external validation cohort is taken retrospectively from Fujian Provincial Cancer Hospital for 2013–2020.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are missing data and survival outcomes modeled?",{"text":117,"@type":113},"Missing data are addressed using multiple imputation methods in R. Survival outcomes are analyzed with Kaplan–Meier and Cox proportional hazards models, and ten machine-learning models are evaluated in Python.",{"name":119,"@type":110,"acceptedAnswer":120},"Does chemotherapy significantly affect overall mortality risk in the overall cohort?",{"text":121,"@type":113},"No. Chemotherapy does not significantly influence overall mortality risk, with HR=0.93 (95% CI 0.82–1.05, P=0.27).",{"name":123,"@type":110,"acceptedAnswer":124},"Which machine-learning model performs best and what is its reported performance?",{"text":125,"@type":113},"The gradient boosting classifier performs best, achieving AUC=0.699 and accuracy=0.708 for predicting survival outcomes.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},370401,1790321842,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Chen et al. European Journal  \nEuropean Journal of Medical Research (2025) 30:218  \n[https://doi.org/10.1186/s40001-025-02425-6](https://doi.org/10.1186/s40001-025-02425-6 of Medical Research)[ of Medical Research](https://doi.org/10.1186/s40001-025-02425-6 of Medical Research)  \n RESEARCH Open Access  \nIdentifying chemotherapy beneficiaries  \nin nasal and paranasal sinus cancers: epidemiological trends and machine learning insights  \nZihan Chen2†, Zongwei Huang1†, Yuhui Pan1, Youliang Weng1, Zijie Wu1, Jing Wang1, Wenxi Wu2, Xinyi Hong2, Xin Chen1 and Sufang Qiu1*  \nAbstract  \nBackground Studies on the epidemiological characteristics, treatment strategies and prognosis of nasal and paranasal sinus cancer are still relatively limited.  \nMethods This study analyzed the age-adjusted incidence rates of nasal and paranasal sinus cancer from 1975 to 2020 using SEER database data. We conducted an in-depth examination of patients diagnosed between 2004 and 2015 with SEER*Stat software. A retrospective study from Fujian Provincial Cancer Hospital (2013–2020) provided an external validation set. Multiple imputation methods in R were used to address missing data. Survival analyses were performed using Kaplan–Meier and Cox proportional hazards models. Additionally, ten advanced machine learning models were utilized and evaluated in Python to predict patient survival outcomes.  \nResults This study analyzed data from 3,190 patients. The annual percent change (APC) in incidence rates per 100 000 person-years was 0.36 until 2012, subsequently decreasing to − 1.79. Among various predictive models, the gradient boosting classifier demonstrated superior performance with an area under the curve (AUC) of 0.699 and an accuracy rate of 0.708. Chemotherapy did not significantly influence overall mortality risk (HR = 0 . 93, 95% CI 0.82–1. 05, P = 0 . 27) . Chemotherapy showed potential benefits in specific patient subgroups.  \nConclusions This study revealed a declining trend in incidence rates beginning in 2012. The gradient boosting model demonstrated robust performance, playing a crucial role in predicting patient prognosis and the significance of chemotherapy.  \nHighlights  \n1. The study analyzed 3,190 patients with nasal and paranasal sinus cancer, showing a slight decrease in incidence since 2012.  \n†Zihan Chen and Zongwei Huang have contributed equally to this work.  \n*Correspondence: Sufang Qiu[sufangqiu@fjmu.edu.cn](sufangqiu@fjmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nChen et al. European Journal of Medical Research (2025) 30:218 Page 2 of 17  \n2. Patient demographics and treatment modalities significantly influenced survival rates, with the gradient boosting classifier being the most effective predictive model, emphasizing the necessity of personalized approaches","cbCaisEvJCK25cBr","https://ap.wps.com/l/cbCaisEvJCK25cBr","pdf",2173678,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n## Highlights\n# Introduction","[{\"question\":\"What data sources and time ranges are used in the study?\",\"answer\":\"Age-adjusted incidence rates are analyzed from 1975 to 2020 using SEER data. Patients diagnosed between 2004 and 2015 are examined with SEER*Stat, and an external validation cohort is taken retrospectively from Fujian Provincial Cancer Hospital for 2013–2020.\"},{\"question\":\"How are missing data and survival outcomes modeled?\",\"answer\":\"Missing data are addressed using multiple imputation methods in R. Survival outcomes are analyzed with Kaplan–Meier and Cox proportional hazards models, and ten machine-learning models are evaluated in Python.\"},{\"question\":\"Does chemotherapy significantly affect overall mortality risk in the overall cohort?\",\"answer\":\"No. Chemotherapy does not significantly influence overall mortality risk, with HR=0.93 (95% CI 0.82–1.05, P=0.27).\"},{\"question\":\"Which machine-learning model performs best and what is its reported performance?\",\"answer\":\"The gradient boosting classifier performs best, achieving AUC=0.699 and accuracy=0.708 for predicting survival outcomes.\"}]","Identifying chemotherapy beneficiaries in nasal and paranasal sinus cancers - epidemiological trends and machine learning insights | PDF",1790188358,43,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2e58b70d67937320360ea5cb1ff81fa.webp",983,1305,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d65f5673e994b06639bfd1c7afdc9ec7.webp",982,1304,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1063076d0e0b6679bb6414989419a43.webp",981,1303,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6fbaed691e53a1ded6143a7f1b9c8858.webp",980,1301]